Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Onychomycosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global onychomycosis treatment market reached a value of US$ 2.94 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.12 Billion by 2027, exhibiting at a CAGR of 5.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete’s foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.

Onychomycosis Treatment Market Trends:

The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global onychomycosis treatment market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on disease type, treatment type, drug class and distribution channel.

Breakup by Disease Type:

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Candidal Onychomycosis
  • Others
     

Breakup by Treatment Type:

  • Laser Therapy
  • Photodynamic Therapy
  • Drug Treatment
     

Breakup by Drug Class:

  • Allylamine
  • Azole
  • Griseofulvin
  • Others
     

Breakup by Distribution Channel:

  • Hospitals and Clinics
  • Online Stores
  • Retail Pharmacies
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Disease Type, Treatment Type, Drug Class, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Onychomycosis Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Disease Type
    6.1    Distal Subungual Onychomycosis
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Proximal Subungual Onychomycosis
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    White Superficial Onychomycosis
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Candidal Onychomycosis
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Treatment Type
    7.1    Laser Therapy
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Photodynamic Therapy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Drug Treatment
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Drug Class
    8.1    Allylamine
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Azole
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Griseofulvin
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Online Stores
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Retail Pharmacies
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Bausch Health Companies Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Cipla Limited
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Dr. Reddy's Laboratories
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Galderma SA
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    GlaxoSmithKline PLC
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Kaken Pharmaceutical Co. Ltd
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
        15.3.7    Lumenis Ltd
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 SWOT Analysis
        15.3.8    Moberg Pharma AB
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
        15.3.9    Novartis AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    The OTC Lab B.V.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2021
Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2021
Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2021
Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2021
Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2021
Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
Table 8: Global: Onychomycosis Treatment Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global onychomycosis treatment market was valued at US$ 2.94 Billion in 2021.

We expect the global onychomycosis treatment market to exhibit a CAGR of 5.50% during 2022-2027.

The high prevalence of onychomycosis among the masses, along with the advent of water-soluble antifungal treatment solutions, is primarily driving the global onychomycosis treatment market.

The sudden outbreak of the COVID-19 pandemic has led to the rising inclination towards e-pharmacy solutions that administer the onychomycosis treatment via providing topical nail lacquers and ointments to maintain nail hygiene.

Based on the disease type, the global onychomycosis treatment market can be categorized into distal subungual onychomycosis, proximal subungual onychomycosis, white superficial onychomycosis, candidal onychomycosis, and others. Among these, distal subungual onychomycosis holds the majority of the total market share.

Based on the treatment type, the global onychomycosis treatment market has been segmented into laser therapy, photodynamic therapy, and drug treatment. Currently, drug treatment represents the largest market share.

Based on the distribution channel, the global onychomycosis treatment market can be bifurcated into hospitals and clinics, online stores, retail pharmacies, and others. Among these, retail pharmacies account for the majority of the total market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global onychomycosis treatment market include Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc., and The OTC Lab B.V.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4